These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16887862

  • 21. Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study.
    Roth S, Bennett R, Caldron P, Hartman R, Mitchell C, Doucette M, Ekholm B, Goldlust B, Lee E, Wilson R.
    Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 2):11-9. PubMed ID: 2181673
    [Abstract] [Full Text] [Related]

  • 22. Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum.
    Langman MJ.
    Ital J Gastroenterol Hepatol; 1999 Feb; 31 Suppl 1():S2-5. PubMed ID: 10379462
    [Abstract] [Full Text] [Related]

  • 23. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
    Cheatum DE, Arvanitakis C, Gumpel M, Stead H, Geis GS.
    Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
    [Abstract] [Full Text] [Related]

  • 24. Therapy of NSAIDs-induced gastropathy.
    La Corte R, Caselli M, Ruina M, Bajocchi G, Alvisi V, Trotta F.
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():37-41. PubMed ID: 9032582
    [Abstract] [Full Text] [Related]

  • 25. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 26. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS, Lems WF, Aertsen J, Bezemer D, Dijkmans BA.
    Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
    [Abstract] [Full Text] [Related]

  • 27. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
    Steen KS, Nurmohamed MT, Visman I, Heijerman M, Boers M, Dijkmans BA, Lems WF.
    Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
    [Abstract] [Full Text] [Related]

  • 28. [De-nol in NSAID-induced gastroduodenal lesions].
    Cataldo MG, D'Aiuto A, Bongiorno A.
    Minerva Dietol Gastroenterol; 1990 Feb; 36(1):27-30. PubMed ID: 2186304
    [Abstract] [Full Text] [Related]

  • 29. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].
    Dobrilla G, Benvenuti S, de Guelmi A.
    Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954
    [Abstract] [Full Text] [Related]

  • 30. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL, Lowry SC, Lanza FL, Schwartz HI, Dodge WE.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1489-98. PubMed ID: 16669964
    [Abstract] [Full Text] [Related]

  • 31. [Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID)--II. Evaluation of therapeutic effects on ulcers under continuous use of NSAID].
    Shiokawa Y, Nobunaga M, Saito T, Sakita T, Miwa T, Nakamura K, Gunji A, Aoki K.
    Ryumachi; 1991 Oct 15; 31(5):572-82. PubMed ID: 1767350
    [No Abstract] [Full Text] [Related]

  • 32. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M.
    Ital J Gastroenterol Hepatol; 1999 Oct 15; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [Abstract] [Full Text] [Related]

  • 33. Inaccurate endoscopy: a better explanation for placebo-associated endoscopic ulcers.
    Graham DY, Chan FK.
    Aliment Pharmacol Ther; 2009 Nov 01; 30(9):955-7; author reply 957-60. PubMed ID: 19807724
    [No Abstract] [Full Text] [Related]

  • 34. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
    Zfass AM, McHenry L, Sanyal AJ.
    Gastroenterologist; 1993 Jun 01; 1(2):165-9. PubMed ID: 8049889
    [Abstract] [Full Text] [Related]

  • 35. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH, Salena BJ, Hunt RH.
    J Gastroenterol; 1994 Jul 01; 29 Suppl 7():34-8. PubMed ID: 7921152
    [Abstract] [Full Text] [Related]

  • 36. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L.
    Gastrointest Endosc Clin N Am; 1996 Jul 01; 6(3):489-504. PubMed ID: 8803564
    [Abstract] [Full Text] [Related]

  • 37. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL, Codispoti JR, Nelson EB.
    Am J Gastroenterol; 1998 Jul 01; 93(7):1051-4. PubMed ID: 9672328
    [Abstract] [Full Text] [Related]

  • 38. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Miller DR.
    Clin Pharm; 1992 Aug 01; 11(8):690-704. PubMed ID: 1511542
    [Abstract] [Full Text] [Related]

  • 39. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T, Sato K, Kudara N, Shinozaki H, Ikeda K, Sato K, Endo M, Orii S, Suzuki K.
    Inflammopharmacology; 2008 Feb 01; 16(1):16-20. PubMed ID: 18256801
    [Abstract] [Full Text] [Related]

  • 40. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.
    J Rheumatol; 1998 Aug 01; 25(8):1602-11. PubMed ID: 9712107
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.